Skip to main content

Genedata Extends Licensing Deal with FDA

NEW YORK (GenomeWeb News) – Genedata today said that it has extended its bioinformatics licensing deal with the US Food and Drug Administration’s National Center for Toxicological Research.
 
NCTR is using Genedata’s Expressionist biomarker discovery platform, which integrates transcriptomics, proteomics, and metabolomics data in a single enterprise software system. Genedata did not disclose the length or further terms of the agreement.
 
Weida Tong, director of the Center for Toxicoinformatics at FDA, said that the agency has used the Expressionist platform in a number of projects including Critical Path and the Liver Toxicity Knowledge Base project.

Filed under

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.